Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
Contaminación interior: formaldehído. OCU Salud n.° 69:12-15.
[2.]
K. Markou, N. Georgopoulos, V. Kyriazopoulou, et al.
Iodine induced hypothyroidism.
Thyroid, 11 (2001), pp. 501-510
[3.]
D. Aliefendioglu, C. Sanli, M. Cakmak, A. Agar, M. Albayrak, O. Evliyaoglu.
Wolff-Chaikoff effect in a newborn: is it an overlooked problem?.
J Pediatr Surg, 41 (2006), pp. 1-3
[4.]
N. Linder, S. Prince, A. Barilai, N. Keller, G. Klinger, I. Shalit, et al.
Disinfection with 10% povidone-iodine versus 0,5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit.
Acta Paediatr, 93 (2004), pp. 205-210
[5.]
V.C. Smith, B.M. Svoren, J.I. Wolfsdorf.
Hypothyroidism in a breast-fed preterm infant resulting from maternal topical iodine exposure.
J Pediatr, 149 (2006), pp. 566-567
[6.]
D. Yilmaz, H.T. Tezic, P. Zorlu, S. Firat, E. Bilaloglu, A.O. Kutlu.
Single dose povidone-iodine on thyroid functions and urinary iodine excretion.
Indian J Pediatr, 70 (2003), pp. 675-677
[7.]
The Contrast Media Safety Committee. European Society of Urogenital Radiology.
Effect of iodinated contrast media on thyroid function in adults.
Eur Radiol, 14 (2004), pp. 902-907
[8.]
W. Gartner, M. Weissel.
Do iodine-containing contrast media induce clinically relevant changes in thyroid function parameters of euthyroid patients within the first week?.
Thyroid, 14 (2004), pp. 521-524
[9.]
D.F. Gardner, Dr. Mars, R.G. Thomas.
Iodine retention and thyroid disfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis.
Am J Kidney Dis, 7 (1986), pp. 471-476
[10.]
K. Sato, K. Okamura, M. Yoshinary, T. Kuroda, H. Ikenoue, K. Okazawa, et al.
Reversible primary hypothyroidism and elevated serum iodine level in patients with renal disfunction.
Acta Endocrinol, 126 (1992), pp. 253-259
[11.]
S. Takeda, T. Michigishi, E. Takazakura.
Iodine-induced hypothyroidism in patients on regular dialysis treatment.
Nephron, 65 (1993), pp. 51-55
[12.]
Y. Bando, Y. Ushiogi, K. Okafuji, D. Toya, N. Tanaka, S. Miura.
Non-autoinmune primary hypothyroidism in diabetc and non-diabetic chronic renal disfunction.
Exp Clin Endocrinol Diab, 110 (2002), pp. 408-415
[13.]
R. Brough, C. Jones.
Iatrogenic iodine as a cause of hypothyrodism in infants with end-stage renal failure.
Pediatr Nephrol, 21 (2006), pp. 400-402
[14.]
F. Bogazzi, F. Raggi, F. Ultimieri, D. Russo, C. Cosci, P. Cecchetti, et al.
Uptake of amiodarone by thyroidal and non-thyroidal cell lines.
J Endocrinol Invest, 29 (2006), pp. 61-66
[15.]
M.D. Trip, W.M. Wiersinga, T.A. Plomp.
Incidence, predictability and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism.
Am J Med, 91 (1991), pp. 507-511
[16.]
P.R. Larsen, T.F. Davies, I.D. Hay.
The thyroid gland.
The Williams text of endocrinology, 9.ª ed., WB Saunders, (1998),
[17.]
H. Perrild, L. Hegedus, P.C. Baastrup, L. Kayser, S. Kastberg.
Thyroid function and ultrasonally determined thyroid size in patients receiving long-term lithium treatment.
Am J Psych, 147 (1990), pp. 1518-1521
[19.]
P.H. Davies, J.A. Franklin.
The effects of drugs on tests of thyroid function.
Eur J Clin Pharmacol, 40 (1991), pp. 439-451
[20.]
E. Lee, P. Chen, H. Rao, J. Lee, L.A. Burmeister.
Effect of acute high dose of dobutamine administration on serum thyrotropin (TSH).
Clin Endocrinol, 50 (1999), pp. 487-492
[21.]
S.I. Sherman, J. Gopal, B.R. Haugen, A.C. Chiu, K. Whaley, P. Nowlakha, et al.
Central hypothyroidism associated with retinoid X receptor-selective ligands.
N Engl J Med, 340 (1999), pp. 1075-1079
[22.]
R.A. Vigersky, A. Filmore-Nassar, A.R. Glass.
Thyrotropin suprresssion by metformin.
J Clin Endocrinol Metab, 91 (2006), pp. 225-227
[23.]
M.H. Samuels, K. Pillote, D. Asher, J.C. Nelson.
Variable effects of nonsteroidal antiinflammatory agents on thyroid test results.
J Clin Endocrinol Metab, 88 (2003), pp. 5710-5716
[24.]
C.M. Jaume, C.M. Mendel, P.H. Frost, F.S. Greenspan, C.W. Laughton.
Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum free throxine concentrations as measured by equilibrium dialysis.
Thyroid, 6 (1996), pp. 79-83
[25.]
S.M. Harmon, C.F. Seifert.
Levothyroxine-cholestiramine interaction reemphasized.
Ann Intern Med, 115 (1991), pp. 658-659
[26.]
M. Centanni, L. Gargano, G. Canettieri, N. Viceconti, A. Franchi, G. Delle Fave, et al.
Thyroxine in goiter, Helicobacter pylori infection, and chronic gastritis.
N Engl J Med, 353 (2006), pp. 1787-1795
[27.]
N. Singh, P.N. Singh, J.M. Herschman.
Effect of calcium carbonate on the absorption of levothyroxine.
JAMA, 283 (2000), pp. 2822
[28.]
N.R.C. Campbell, B.B. Hasinoff, H. Stalts, B. Rao, N.C. Wong.
Ferrous sulfate reduces thyroxine efficacy in patients with hypothyroidism.
Ann Intern Med, 117 (1992), pp. 1010-1013
[29.]
Y. Liel, A.D. Sperber, S. Shany.
Nonspecific intestinal adsorption of levothyroxine by aluminum hydroxide.
Am J Med, 97 (1994), pp. 363
[30.]
J.G. Cooper, K. Harboe, S.K. Frost, O. Skadberg.
Ciprofloxacin interacts with thyroid replacement therapy.
BMJ, 330 (2005), pp. 1002
[31.]
E.S. Siraj, M.K. Gupta, S.S. Reddy.
Raloxifene causing malabsorption of levothyroxine.
Arch Intern Med, 163 (2003), pp. 1367-1370
[32.]
P.G. Currant, L.J. De Groot.
The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland.
Endocr Rev, 12 (1991), pp. 135
[33.]
J.I. Isojarvi, J. Turkka, A.J. Pakarinen, M. Kotila, J. Rattya, V.V. Myllyla.
Thyroid function in men taking carbamacepine, oxcarbazepine, or valproate for epilepsy.
Epilepsia, 42 (2001), pp. 930-934
[34.]
L.K. Vainionpaa, K. Mikkonen, J. Rattia, M. Knip, A.J. Pakarinen, V.V. Myllyla, et al.
Thyroid function in girls with epilepsy with carbamazepine, oxcarbazepine, or valproate monotherapy and after withdrawal of medication.
Epilepsia, 45 (2004), pp. 197-203
[35.]
A. Cansu, A. Serdaroglu, O. Camurdan, T. Hirfanoglu, A. Bideci, K. Gucuyener.
The evaluation of thyroid functions, thyroid antibodies, and thyroid volumes in children with epilepsy during short-term administration of oxcarbazepine and valproate.
Epilepsia, 47 (2006), pp. 1855-1859
[36.]
J.E. Lawrence, S.H. Lamm, S. Pino, K. Richman, L.E. Braverman.
Thyroid, 10 (2000), pp. 659-663
[37.]
L.E. Braverman, E.N. Pearce, X. He, S. Pino, M. Seeley, B. Beck, et al.
Effects of six months of daily low-dose perchlorate exposure on thyroid function in healthy volunteers.
J Clin Endocrinol Metab, 91 (2006), pp. 2721-2724
[38.]
L.E. Braverman, X. He, S. Pino, M. Cross, B. Magnani, S.H. Lamm, et al.
The effect of perchlorate, thyocyanate, and nitrate on thyroid function in workers exposed to perchlorate long term.
J Clin Endocrinol Metab, 90 (2005), pp. 700-706
[39.]
V.F. Brauer, H. Below, A. Kramer, D. Fuhrer, R. Paschke.
The role of thiocyanate in the etiology of goiter in an industrial metropolitan area.
Eur J Endocrinol, 154 (2006), pp. 229-235
[40.]
A.C. Ferreira, P.C. Lisboa, K.J. Oliveira, L.P. Lima, I.A. Barros, D.P. Carvalho.
Inhibitions of thyroid type 1 deiodinase activity by flavonoids.
Food Chem Toxicol, 40 (2002), pp. 913-917
[41.]
A.C. Ferreira, J.C. Neto, A.C. da Silva, R.M. Kuster, D.P. Carvalho.
Inhibition of thyroid peroxidase by Myrcia uniflora flavonoids.
Chem Res Toxicol, 19 (2006), pp. 351-355
[42.]
D.R. Doerge, H.C. Chang.
Inactivation of thyroid peroxidase by soy isoflavones, in vitro and in vivo.
J Chromatogr B Analyt Technol Biomed Life Sci, 777 (2002), pp. 269-279
[43.]
D.R. Doerge, D.M. Sheehan.
Goitrogenic and estrogenic activity of soy isoflavones.
Environ Health Perspect, 110 (2002), pp. 349-353
[44.]
J. Milerova, J. Cerovska, V. Zamarazil, R. Bilek, O. Lapcik, R. Hampl.
Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters.
Clin Chem Lab Med, 44 (2006), pp. 171-174
[45.]
W.F. Heidenreich, T.I. Bogdanova, A.G. Biryukov, N.D. Tronko.
Time trends of thyroid cancer incidence in Ukraine after the Chernobil accident.
J Radiol Prot, 24 (2004), pp. 283-293
[46.]
E.D. Williams.
Chernobyl and thyroid cancer.
J Surg Oncol, 94 (2006), pp. 670-677
[47.]
E. Cardis, G. Howe, E. Ron, V. Bebeshko, T. Bogdanova, A. Bouville, et al.
Cancer consequences of the Chernobyl accident: 20 years on.
J Radiol Prot, 26 (2006), pp. 127-140
[48.]
M.D. Tronko, G.R. Howe, T.I. Bogdanova, A.C. Bouville, O.V. Epstein, A.B. Brill, et al.
A cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: thyroid cancer in Ukraine detected during first screening.
J Nat Cancer Inst, 98 (2006), pp. 897-903
[49.]
I. Likhtarov, L. Kovgan, S. Vavilov, M. Chepurny, E. Ron, J. Lubin, et al.
Post-Chernobyl thyroid cancer in Ukraine. Report 2: risk analysis.
Radiat Res, 166 (2006), pp. 375-386
[50.]
M.D. Tronko, A.V. Brenner, V.A. Olijnik, J. Robbins, O.V. Epstein, R.J. McConnell, et al.
Autoinmune thyroiditis and exposure to iodine 131 in the ukrainian cohort study of thyroid cancer and other thyroid diseases after the Chernobyl accident: results from the first scrrening cycle (1998-2000).
J Clin Endocrinol Metab, 91 (2006), pp. 4344-4351
[51.]
G. Giovannelli.
Radioiodine and thyroid carcinoma: KI prophylaxis in children.
Acta Biomed, 75 (2004), pp. I-XIII
Copyright © 2008. Sociedad Española de Endocrinología y Nutrición
